Abstract

We examined criteria for the diagnosis and grading of the Parkinson's disease phenotype (PDP) using postmortem tissue and clinical features.We used cases of the PDP, incidental Lewy body disease (ILBD), other neurodegenerative diseases and control subjects. We stained paraffin slides and free‐floating tissue sections from different academic centers for H&E. StereoInvestigator (MBF, Williston VT) was used for counting. Features counted included: neuromelanin (NM) containing neurons, NM+ cells, NM– neurons, NM+ macrophages (MPs), NM+ clusters of MPs, free NM, LBs, pale bodies and other intraneuronal inclusions. Principle component analysis followed by linear discriminant analysis will be used with other clinical features to compare the levels of these morphological factors.Data presented will include cases not used, counts from paraffin and free‐floating sections, repeat counting, inter‐rater reliability, and statistical analysis.Disagreements were identified. Criteria, counts, morphology, and time required for counting varied between the two methods. Both methods have advantages and disadvantages. The use of additional cases to refine this approach may demonstrate which method is superior and how they relate to each other.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.